NPI: 1033183397 · BAKERSFIELD, CA 93309 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 02/14/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 02/14/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 23,027 | $1.40M |
| 2019 | 13,882 | $1.09M |
| 2020 | 14,595 | $1.14M |
| 2021 | 13,065 | $1.01M |
| 2022 | 7,194 | $703K |
| 2023 | 6,405 | $864K |
| 2024 | 5,753 | $819K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 30,747 | 2,343 | $7.01M |
| J1756 | Injection, iron sucrose, 1 mg | 6,485 | 1,472 | $8K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 24,908 | 1,562 | $7K |
| J1270 | Injection, doxercalciferol, 1 mcg | 16,631 | 1,222 | $4K |
| 90674 | 44 | 37 | $1K | |
| 83970 | 685 | 520 | $519.40 | |
| 83550 | 410 | 284 | $387.40 | |
| 83540 | 495 | 370 | $383.20 | |
| 85041 | 578 | 485 | $362.60 | |
| 82728 | 450 | 344 | $300.48 | |
| A4657 | Syringe, with or without needle, each | 1,359 | 822 | $268.26 |
| 85048 | 536 | 458 | $268.08 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 39 | 24 | $212.27 |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 554 | 314 | $142.12 |